InvestorsHub Logo
Followers 105
Posts 16534
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Monday, 06/17/2024 8:38:54 AM

Monday, June 17, 2024 8:38:54 AM

Post# of 172
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBIO News